Clinical Trials Directory

Trials / Completed

CompletedNCT05808777

Validation of the ICH Score for the Prediction of 12-month Functional Outcome in Patients With Primary Intracerebral Hemorrhage

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to analyze the validity of the intracerebral hemorrhage (ICH) Score and a new modified ICH score for the prediction of 12-month functional outcome in patients with primary ICH. Participants who were admitted to NTUH rehabilitation ward will be followed up to 12 months after the onset of ICH. The follow-up will be conducted by phone interviews.

Detailed description

The ICH Score had been utilized to predict the 30-day mortality after acute intracerebral hemorrhage (ICH), but there's still no reliable tool in predicting the long-term functional outcome in ICH patients. Recently, there have been some studies that use ICH score to predict the prognosis of functional outcome in ICH patients. However, most studies included patients in western societies. Relevant studies in Taiwan were scarce. The present study will follow up the patients with ICH, who were admitted to NTUH rehabilitation ward, up to 12 months post stroke. The follow-up will be conducted by phone interviews at certain time after the onset of ICH. Investigators aim to analyze the validity of the ICH Score for the prediction of 12-month functional outcome in patients with primary ICH. Investigators will also add other variables to see if the revised score could better predict the prognosis among ICH patients.

Conditions

Interventions

TypeNameDescription
OTHERPhone interviewA interview follow-up with a physician by phone was performed at 12 months after the onset of ICH.

Timeline

Start date
2019-06-24
Primary completion
2022-06-23
Completion
2022-06-23
First posted
2023-04-11
Last updated
2023-04-11

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05808777. Inclusion in this directory is not an endorsement.